NewcelX Ltd. (NCEL) vs Profusa, Inc. Common Stock (PFSA)

A side-by-side comparison of NewcelX Ltd. and Profusa, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NCEL

NewcelX Ltd.

$1M

$2.94HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT

PFSA

Profusa, Inc. Common Stock

$2M

$1.66HealthcareDelayed quote: Oct 6, 2026, 1:25 PM EDT

Total return — NCEL vs PFSA

growth of $100 · dividends reinvested · last 1y

NCEL -86.4% (-86.4%/yr)PFSA -100.0% (-100.0%/yr)NCEL compounded faster over this window

Log scale — wide-divergence pair

NCEL PFSA

NCEL vs PFSA: by the numbers

•PFSA is the larger company ($2M vs $1M market cap).

Metrics side by side

Valuation

Metric	NCEL	PFSA
P/B ratio	0.22	N/A

Profitability

Metric	NCEL	PFSA
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-114.48%	N/A
ROIC	-32.53%	N/A

Growth (annualized)

Metric	NCEL	PFSA
Total return CAGR (5Y)	-68.96%	N/A

Go deeper

Full NCEL analysis Full PFSA analysis Interactive comparison tool

Dig into the metrics

NewcelX ROE Profusa, Inc. Common Stock ROE NewcelX operating margin Profusa, Inc. Common Stock operating margin NewcelX revenue growth Profusa, Inc. Common Stock revenue growth NewcelX free cash flow Profusa, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.